论文部分内容阅读
糖化血红蛋白(glycated hemoglobin,HbA1c)是糖尿病患者监测血糖控制的常规衡量指标,是未来发生心血管风险的标志。果糖胺和糖化白蛋白是短期血糖控制的观察指标,但它们与心血管预后的相关性尚不清楚。方法和结果:纳入1990-1992年(基线)以社区为基础的动脉粥样硬化风险研究中有或无糖尿病的研究对象11 104人,均检测过果糖胺和糖化白蛋白水平。评估果糖胺和糖化白蛋白与冠状动脉性心脏病
Glycated hemoglobin (HbA1c) is a common measure of glycemic control in patients with diabetes and is a hallmark of future cardiovascular risk. Fructosamine and glycated albumin are indicators of short-term glycemic control, but their relevance to cardiovascular outcomes remains unclear. METHODS AND RESULTS: A total of 11 104 study subjects with or without diabetes who were included in the community-based atherosclerotic risk study from 1990 to 1992 (baseline) were enrolled in the study and were given fructosamine and glycated albumin levels. Assessment of fructosamine and glycated albumin and coronary heart disease